CytoGenix Licenses Trovec Antisense Delivery System To PharmaGenix

CytoGenix Inc. has executed the first license for the use of its proprietary single stranded DNA intracellular expression vector (TroVec) to PharmaGenix LLC., owned jointly by CYGX and PCCA (Professional Compounding Centers of America Inc). PharmaGenix is the first company to combine the traditional science and skills of compounding pharmacists with those molecular biologists and geneticists in the search for new, more effective, and longer lasting treatment of a wide range conditions in any living organism.

The initial focus of PharmaGenix will be the development of products using nucleic acid constituents in nutritional and topical applications that are not regulated by the FDA as prescription drugs.

Get Steroids

Dragon Pharma is specialized in the manufacturing of high quality steroid drugs Trenbolone Acetate for Sale.